Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis.
Papadopoulou C, Martin N, Rafiq N, McCann L, Varner G, Nott K, Compeyrot-Lacassagne S, Leandro M, Foley C, Warrier K, Green N, Wan M, Dehbi HM, Whitehead J, Eleftheriou D, Brogan P. Papadopoulou C, et al. Among authors: warrier k. Rheumatology (Oxford). 2024 Jul 29;63(12):3271-8. doi: 10.1093/rheumatology/keae392. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39073903 Free PMC article.
Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.
Campanilho-Marques R, Almeida B, Deakin C, Arnold K, Gallot N, de Iorio M, Nistala K, Pilkington CA, Wedderburn LR; Juvenile Dermatomyositis Research Group. Campanilho-Marques R, et al. Arthritis Care Res (Hoboken). 2016 Oct;68(10):1514-21. doi: 10.1002/acr.22867. Epub 2016 Sep 16. Arthritis Care Res (Hoboken). 2016. PMID: 26881696 Free PMC article.
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope.
Mercer L, Abhishek A, Kavirayani A, Ahmed A, Davidson A, Foulkes A, Jones C, Nash C, Rose-Parfitt E, Dhillon E, Zabate G, Twohig H, De Vere H, Scott J, Reynolds J, Holmes J, Hartley K, Warrier K, Nowak K, Parsons K, Bechman K, Bray L, Adikari M, Wood N, Faithfull N, Gullick N, Saha P, Heaton R, Deepak S, Hider S, Khalid S, Said SS, Ryan S, Kyle S, Raghuvanshi S, Tan SY, Shivamurthy V, Galloway J. Mercer L, et al. Among authors: warrier k. Rheumatol Adv Pract. 2024 Jul 12;8(3):rkae077. doi: 10.1093/rap/rkae077. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 39006537 Free PMC article. Review.
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients.
Nguyen HD, Jouen F, Déchelotte B, Cordel N, Gitiaux C, Bodemer C, Quartier P, Belot A, O'Brien K, Cancemi D, Melki I, Fabien N, Tansley S, Boyer O, Wedderburn LR, Bader-Meunier B; UK JDM Cohort and Biomarker Study. Nguyen HD, et al. Rheumatology (Oxford). 2024 Oct 1;63(10):e281-e284. doi: 10.1093/rheumatology/keae182. Rheumatology (Oxford). 2024. PMID: 38498839 Free PMC article. No abstract available.
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy.
Oldroyd AGS, Lilleker JB, Amin T, Aragon O, Bechman K, Cuthbert V, Galloway J, Gordon P, Gregory WJ, Gunawardena H, Hanna MG, Isenberg D, Jackman J, Kiely PDW, Livermore P, Machado PM, Maillard S, McHugh N, Murphy R, Pilkington C, Prabu A, Rushe P, Spinty S, Swan J, Tahir H, Tansley SL, Truepenny P, Truepenny Y, Warrier K, Yates M, Papadopoulou C, Martin N, McCann L, Chinoy H; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Oldroyd AGS, et al. Among authors: warrier k. Rheumatology (Oxford). 2022 May 5;61(5):1760-1768. doi: 10.1093/rheumatology/keac115. Rheumatology (Oxford). 2022. PMID: 35355064 Free PMC article. No abstract available.
39 results